drug coated angioplasty balloon (DCB) platform is designed to treat peripheral arterial disease (download PDF brochure
and ATK/BTK technical sheets
). Stellarex uses EnduraCoatTM
technology, a durable, uniform coating designed to maximize drug transfer to the vessel wall and minimize downstream drug loss during transit and upon inflation. Stellarex is not approved in the United States.
Instructions for Use >